We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
-9.57%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$1.21B
AUM Growth
+$57.1M
Cap. Flow
+$88M
Cap. Flow %
7.29%
Top 10 Hldgs %
18.29%
Holding
1,231
New
406
Increased
209
Reduced
153
Closed
411

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$37.1M
2
PHYS icon
Sprott Physical Gold
PHYS
+$20.4M
3
SPPP
Sprott Physical Platinum and Palladium Trust
SPPP
+$9.97M
4
JIH
Juniper Industrial Holdings, Inc.
JIH
+$9.06M
5
TIF
Tiffany & Co.
TIF
+$8.72M

Top Sells

Rank Stock Value
1
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$18.8M
2
JIH.U
Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00
JIH.U
+$9.4M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$9.11M
4
MFAC.U
Megalith Financial Acquisition Corp. Units, each consisting of one share of Class A Common Stock, an
MFAC.U
+$8.27M
5
THCAU
Tuscan Holdings Corp. II Unit
THCAU
+$6.68M

Sector Composition

Rank Sector Weight
1 Healthcare 12.1%
2 Technology 11.49%
3 Consumer Discretionary 5.07%
4 Financials 4.69%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
376
CALL
Cytokinetics
CYTK
$10.7B
$680K 0.06%
+577
New +$7.36K
ESRT icon
377
Empire State Realty Trust
ESRT
$845M
$678K 0.06%
75,701
-319
-0.4% -$3.9K
ACTG icon
378
Acacia Research
ACTG
$439M
$677K 0.06%
305,008
+59,377
+24% +$145K
SCTL
379
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$675K 0.06%
+82,617
New +$1.15M
BMRN icon
380
BioMarin Pharmaceuticals
BMRN
$11.6B
$674K 0.06%
+7,980
New +$688K
FMB icon
381
First Trust Managed Municipal ETF
FMB
$2.06B
$673K 0.06%
+12,455
New +$692K
MRK icon
382
Merck
MRK
$317B
$673K 0.06%
9,167
-26,826
-75% -$2.11M
EDU icon
383
New Oriental
EDU
$9.06B
$670K 0.06%
6,193
-12,989
-68% -$1.67M
CIGI icon
384
Colliers International
CIGI
$5.17B
$666K 0.06%
13,866
+3,466
+33% +$260K
AXSM icon
385
PUT
Axsome Therapeutics
AXSM
$11B
$665K 0.06%
113
+68
+151% +$5.54K
SCPE.U
386
DELISTED
SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o
SCPE.U
$663K 0.05%
64,256
-10,744
-14% -$111K
AVDL
387
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
$660K 0.05%
+831
New +$6.38K
NBIX icon
388
CALL
Neurocrine Biosciences
NBIX
$16.4B
$658K 0.05%
+76
New +$7.44K
CELUW
389
DELISTED
Celularity Inc
CELUW
$657K 0.05%
67,056
+33,722
+101% +$28.9K
CARO
390
DELISTED
Carolina Financial Corp.
CARO
$657K 0.05%
+25,401
New +$886K
ARGX icon
391
argenx
ARGX
$54.3B
$655K 0.05%
+4,972
New +$728K
LACQ
392
DELISTED
Leisure Acquisition Corp.
LACQ
$655K 0.05%
+60,000
New +$624K
DPHCU
393
DELISTED
DiamondPeak Holdings Corp. Units
DPHCU
$653K 0.05%
+65,000
New +$667K
PNW icon
394
Pinnacle West Capital
PNW
$12.3B
$652K 0.05%
+8,603
New +$780K
CCXI
395
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$651K 0.05%
+162
New +$6.88K
ACRE
396
Ares Commercial Real Estate
ACRE
$261M
$645K 0.05%
+92,341
New +$1.31M
CSTE icon
397
Caesarstone
CSTE
$80.2M
$644K 0.05%
60,942
+942
+2% +$11.5K
NAV
398
DELISTED
Navistar International
NAV
$635K 0.05%
+38,536
New +$1.13M
CASH icon
399
Pathward Financial
CASH
$1.88B
$629K 0.05%
28,945
-25,945
-47% -$855K
ELAN icon
400
Elanco Animal Health
ELAN
$13.1B
$627K 0.05%
+28,007
New +$767K
14 15
16
17 18

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q1 2020 Portfolio in Review

As of Q1 2020, Boothbay Fund Management held 1,231 positions worth $1.21B, up 5% from $1.15B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boothbay Fund Management deployed $88M of net new capital in Q1 2020, opening 406 new positions and adding to 209 existing holdings. Its largest new stake was Sprott Physical Gold: 1,601,344 shares worth $21M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $6M trimmed.

  • Boothbay Fund Management's largest Q1 2020 buy was Sprott Physical Gold: 1,601,344 shares worth $21M.
  • Boothbay Fund Management added most to Allergan plc in Q1 2020, an estimated $37.1M increase.
  • Boothbay Fund Management's biggest Q1 2020 reduction was NXP Semiconductors, cutting an estimated $6M.
  • Boothbay Fund Management fully exited Sprott Physical Gold and Silver Trust in Q1 2020, selling an estimated $18.8M.
  • Boothbay Fund Management's ten largest holdings make up 18% of its $1.21B portfolio in Q1 2020.
  • Boothbay Fund Management opened 406 new positions and closed 411 in Q1 2020.
  • Boothbay Fund Management's portfolio value rose 5% quarter-over-quarter to $1.21B.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.